Viewing Study NCT05347992



Ignite Creation Date: 2024-05-06 @ 5:32 PM
Last Modification Date: 2024-10-26 @ 2:31 PM
Study NCT ID: NCT05347992
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2023-02-24
First Post: 2022-04-11

Brief Title: ELEVATE - Empower Lupus Erythematosus Patients Via Allowing RemoTe Evaluation
Sponsor: DxTerity Diagnostics
Organization: DxTerity Diagnostics

Study Overview

Official Title: ELEVATE - Empower Lupus Erythematosus Patients Via Allowing RemoTe Evaluation
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ELEVATE
Brief Summary: To explore the potential for use of DxTeritys AIP IFN-1 test as personalized guided care and monitoring module in patients with Systemic lupus erythematosusSLE using consented patient health information
Detailed Description: Explore and demonstrate concordance between self-collected samples and traditional phlebotomist venous draw for DxTerity AIP module and biomarkers like C3 C4 anti dsDNA and CRP in SLE participants with self-reported outcomes and medical record data

The study will collect blood samples and self-reported information for SLE subjects up to 5000 participants in Phase I with a subset of 1000 continuing to Phase II with Medical records Study participants will be recruited using a combination of digital media including social media advertising bloggers emails Enrollment and qualification will be done along with consented retrieval of medical records using a study specific mobile app

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None